Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation

Cerebral Cortex

Volumn 18, Issue 8, 2008, Pages 1748-1757

  Antonelli, Tiziana ^a   Tomasini, Maria C ^a   Fournier, Jacqueline ^b   Mazza, Roberta ^a   Tanganelli, Sergio ^a   Pirondi, Stefania ^c   Fuxe, Kjell ^d   Luca, Ferraro ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b SANOFI   (France)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cortical cell cultures; Ischemia; Lactate dehydrogenase; MAP2 immunoreactivity; Neurotensin receptor antagonist

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CASPASE 3; GLUCOSE; GLUTAMIC ACID; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR ANTAGONIST; OXIDOREDUCTASE; OXYGEN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN ISCHEMIA; CHROMATIN CONDENSATION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVITY; EXCITOTOXICITY; IMMUNOREACTIVITY; MEASUREMENT; MORPHOLOGY; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT;

ANIMALS; APOPTOSIS; CELL DEATH; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; EXTRACELLULAR FLUID; GLUCOSE; GLUTAMIC ACID; NEURONS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN;

EID: 47649103685     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhm217     Document Type: Article

References (45)

1. Allen GV, Cheung RT, Cechetto DF. 1995. Neurochemical changes following occlusion of the middle cerebral artery in rats. Neuroscience. 66:1037-1050.
2. Antonelli T, Ferraro L, Fuxe K, Finetti S, Fournier J, Tanganelli S, De Mattei M, Tomasini MC. 2004. Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity. Cereb Cortex. 14:466-473.
3. Antonelli T, Fuxe K, Tomasini MC, Mazzoni E, Agnati LF, Tanganelli S, Ferraro L. 2007. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain Relevance for neurodegenerative diseases and their treatment. Prog Neurobiol. 83:92-109.
4. Antonelli T, Tomasini MC, Finetti S, Giardino L, Calza L, Fuxe K, Soubriè P, Tanganelli S, Ferraro L. 2002. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture. J Neurosci Res. 70:766-773.
5. Arundine M, Tymianski M. 2004. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci. 61:657-668.
6. Babcock AM, Baker DA, Hallock NL, Lovec R, Lynch WC, Peccia JC. 1993. Neurotensin-induced hypothermia prevents hippocampal neuronal damage and increased locomotor activity in ischemic gerbils. Brain Res Bull. 32:373-378.
7. Bissette G, Nemeroff CB, Loosen PT, Prange AJ, Lipton MA. 1976. Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin. Nature. 262:607-609.
8. Buddle M, Eberhardt E, Ciminello LH, Levin T, Wing R, DiPasquale K, Raley-Susman KM. 2003. Microtubule-associated protein 2 (MAP2) associates with the NMDA receptor and is spatially redistributed within rat hippocampal neurons after oxygen-glucose deprivation. Brain Res. 978:38-50.
9. Chen L, Yung KK, Yung WH. 2006. Neurotensin selectively facilitates glutamatergic transmission in globus pallidus. Neuroscience. 141:1871-1878.
10. Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM. 1998. Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology. 37:1419-1429.
11. Choi DW, Koh IY, Peters S. 1988. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 7:1384-1400.
12. Choi DW, Monyer H, Giffard RG, Goldberg MP, Christine CW. 1990. Acute brain injury, NMDA receptors, and hydrogen ions: observations in cortical cell cultures. Adv Exp Med Biol. 268:501-504.
13. Corbett D, Thornhill J. 2000. Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia. Brain Pathol. 10:145-152.
14. Culmsee C, Junker V, Kremers W, Thal S, Plesnila N, Krieglstein J. 2004. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke. 35:1197-1202.
15. Dubuc I, Costentin J, Doulut S, Rodriguez M, Martinez J, Kitabgi P. 1992. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse. Eur J Pharmacol. 219:327-329.
16. Esquenazi S, Monnerie H, Kaplan P, Le Roux P. 2002. BMP-7 and excess glutamate: opposing effects on dendrite growth from cerebral cortical neurons in vitro. Exp Neurol. 176:41-54.
17. Ferraro L, Antonelli T, O'Connor WT, Fuxe K, Soubriè P, Tanganelli S. 1998. The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci. 18:6977-6989.
18. Ferraro L, Tanganelli S, O'Connor WT, Bianchi C, Ungerstedt U, Fuxe K. 1995. Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. Synapse. 20:362-364.
19. Ferraro L, Tomasini MC, Fernandez M, Bebe BW, O'Connor WT, Fuxe K, Glennon JC, Tanganelli S, Antonelli T. 2001. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual probe microdialysis study in intact conscious rat brain. Neuroscience. 102:113-120.
20. Ferraro L, Tomasini MC, Siniscalchi A, Fuxe K, Tanganelli S, Antonelli T. 2000. Neurotensin increases endogenous glutamate release in rat cortical slices. Life Sci. 66:927-936.
21. Goldberg MP, Choi DW. 1993. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 13:3510-3524.
22. Gordon CJ. 2001. The therapeutic potential of regulated hypothermia. Emerg Med J. 18:81-89.
23. Gully D, Jeanjean F, Poncelet M, Steinberg R, Soubrie P, Le Fur G, Maffrand JP. 1995. Neuropharmacological profile of non-peptide neurotensin antagonists. Fundam Clin Pharmacol. 9:513-521.
24. Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N, et al. 1997. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther. 280:802-812.
25. Huerta S, Goulet EJ, Huerta-Yepez S, Livingston EH. 2007. Screening and detection of apoptosis. J Surg Res. 139:143-156.
26. Ioudina M, Uemura E, Greenlee HW. 2004. Glucose insufficiency alters neuronal viability and increases susceptibility to glutamate toxicity. Brain Res. 1004:188-192.
27. Johnston MV, Trescher WH, Ishida A, Nakajima W. 2001. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res. 49:735-741.
28. Katz LM, Young A, Frank JE, Wang Y, Park K. 2004. Neurotensin-induced hypothermia improves neurologic outcome after hypoxicischemia. Crit Care Med. 32:806-810.
29. Kinkead B, Nemeroff CB. 2004. Neurotensin, schizophrenia, and antipsychotic drug action. Int Rev Neurobiol. 59:327-349.
30. Kokko KP, Hadden MK, Price KL, Orwig KS, See RE, Dix TA. 2005. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Neuropharmacology. 48:417-425.
31. Krieger DW, Yenari MA. 2004. Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke. 35:1482-1489.
32. Kuhn J, Meissner C, Oehmichen M. 2005. Microtubule-associated protein 2 (MAP2)-a promising approach to diagnosis of forensic types of hypoxia-ischemia. Acta Neuropathol (Berl). 110:579-586.
33. Lan JY, Skeberdis VA, Jover T, Grooms SY, Lin Y, Araneda RC, Zheng X, Bennett MV, Zukin RS. 2001. Protein kinase C modulates NMDA receptor trafficking and gating. Nat Neurosci. 4:382-390.
34. Li GL, Farooque M, Lewen A, Lennmyr F, Holtz A, Olsson Y. 2000. MAP2 and neurogranin as markers for dendritic lesions in CNS injury. An immunohistochemical study in the rat. APMIS. 108:98-106.
35. Loo DT, Rillema JR. 1998. Measurement of cell death. Methods Cell Biol. 57:251-264.
36. Matesic D, Lin RCS. 1994. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forbrain. J Neurochem. 63:1012-1020.
37. Matsuyama S, Fukui R, Higashi H, Nishi A. 2003. Regulation of DARPP-32 Thr75 phosphorylation by neurotensin in neostriatal neurons: involvement of glutamate signalling. Eur J Neurosci. 18:1247-1253.
38. Mueller AL, Artman LD, Balandrin MF, Brady E, Chien Y, Delmar EG, George K, Kierstead A, Marriott TB, Moe ST, et al. 1999. NPS 1506, a novel NMDA receptor antagonist and neuroprotectant. Review of preclinical and clinical studies. Ann NY Acad Sci. 890:450-457.
39. Pirondi S, Fernandez M, Schmidt R, Hokfelt T, Giardino L, Calza L. 2005. The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells. J Neurochem. 95:821-833.
40. Simm A, Bertsch G, Frank H, Zimmermann U, Hoppe J. 1997. Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci. 110:819-828.
41. Strasser U, Fischer G. 1995. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J Neurosci Methods. 57:177-186.
42. Torup L, Borsdal J, Sager T. 2003. Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischemia. Neurosci Lett. 351:173-176.
43. Vanicky I, Balchen T, Diemer NH. 1995. Alterations in MAP2 immunostainability after prolonged complete brain ischemia in the rat. Neuroreport. 7:161-164.
44. Young C, Tenkova T, Dikranian K, Olney JW. 2004. Excitotoxic versus apoptotic mechanisms of neuronal cell death in perinatal hypoxia/ischemia. Curr Mol Med. 4:77-85.
45. Zipfel GJ, Babcock DJ, Lee JM, Choi DW. 2000. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma. 17:857-869.